Table 2.

List of drugs under clinical trials trial against dormant M.tb.

Drug	Target	Developmental stage	Ref
CPZEN-45	WecA enzyme	Late-stage pre-clinical development	(Takahashi et al., 2013; Zhang et al., 2014)
Nitrobenzothiazinone (BTZ-043)	DprE1	Ia/IIb stage trial	(Ishizaki et al., 2013)
Allylaminomethanone-A, 7-methoxy-2-naphthol	MenA	Lead identification stage	(Makarov et al., 2009)
Salicylanilide esters	ICL	Not entered clinical trial	(Shetye et al., 2020)
HC106A	DosRST	Hit identification stage	(Lee et al., 2015)
PDKA analogues	Malate synthase	Hit identification stage	(Zheng et al., 2017)
(3-(3,4-Dichlorophenyl) ureido) benzoic acid	Cysteine synthase	Hit identification stage	(Schnell et al., 2015)
4-methoxy-2-(pyridin-4-yl) thiazole-5-carboxylic acid	Lysine ϵ-Aminotransferase (LAT)	Hit identification stage	(Betts et al., 2002)